Virginia localities are preparing to move into phase 1C as more vaccines become available to more of the population. One of ...

(Reuters) -The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Keytruda is set to lose exclusivity in 2028, meaning Summit may face competition from cheaper biosimilars. Meanwhile, other ...

By Akin Nazli in Belgrade Ugur Sahin, owner of BioNTech (Nasdaq/BNTX), has been ranked second in Forbes Turkey’s Top 100 ...

Clinical trials are the cornerstone of medical innovation, offering a rigorous framework to evaluate the safety and ...

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

When the smoke cleared, BioNTech's shares closed the day more than 6% lower. The Food and Drug Administration (FDA), a ...

BioNTech (NasdaqGS:BNTX) recently appointed Ramón Zapata-Gomez as its new CFO, a move reflecting the company's focus on realigning its financial strategy, particularly in oncology. Despite confirming ...

Here are the latest rating downgrades by Seeking Alpha analysts: ConocoPhillips (NYSE:COP). Buy to hold by Michael ...

Research teams across Canada are now building mRNA to expand the potential of RNA vaccines beyond infectious diseases.

In late April, Summit Therapeutics revealed interim OS data from HARMONi-2 for its PD-1/VEGF bispecific antibody, ivonescimab ...